COVID-19 Research


The recent declaration of COVID-19 as a global pandemic by the World Health Organisation has prompted us to make the relevant Data, Research and Resources at the Vinod Scaria Lab at CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB) in an open format to ensure that they are widely accessible as well as relevant. The programme would embrace the concepts of open-source and open access.

Resources for Genetic Epidemiology of SARS-CoV-2

Publications and Preprints


Gupta, V., Bhoyar, R. C., Jain, A., Srivastava, et al, Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2. Clinical Infectious Diseases (2020) ciaa1451,
Govindaraj GM, Krishnakumar P, Scaria V, Athulya E, Ajithkumar VT, Dongre AR. Building on an Ad Hoc Covid-19 Response to Enhance Community-based Care for Vulnerable Children in Kerala, India. NEJM Catal Innov Care Deliv. (2020) doi: 10.1056/CAT.20.0543.
Banu S, Jolly B, Mukherjee M, Singh P, Khan S, Zaveri L, Shambhavi S, Gaur N, Mishra RK, Scaria V, Sowpati DT A distinct phylogenetic cluster of Indian SARS-CoV-2 isolates Open Forum Infectious Diseases, (2020), ofaa434,
Jain A, Rophina M, Mahajan S, Krishnan BB, Sharma M, Mandal S, Fernandez T, Sultanji S, Mathew S, Sivasubbu S, Scaria V Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays International Journal of Infectious Diseases
Bhoyar RC, et al, High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next generation sequencing PLoS ONE (2021) Accepted
Radhakrishnan C, Divakar MK, Jain A et al, Initial insights into the genetic epidemiology of SARS-CoV-2 isolates from Kerala suggest local spread from limited introductions Frontiers in Genetics (2021) Accepted
Yadav SP, Thakkar D, Bhoyar RC, Jain A, Wadhwa T, Imran M, Jolly B, Divakar MK, Kapoor R, Rastogi N, Sharma D, Sehgal P, Ranjan G, Sivasubbu S, Sarma S, Scaria VAsymptomatic reactivation of SARS-CoV-2 in a child with neuroblastoma characterised by whole genome sequencing,IDCases (2021), e01018,
Rani, PR., Imran M, Lakshmi J, Jolly B, Jain A, Surekha A, Senthivel V, et al.Symptomatic Reinfection of Sars-cov-2 with Spike Protein Variant N440K Associated with Immune Escape. J Med Virol . 2021 Apr 5. doi: 10.1002/jmv.26997
J, Beena P., Bani Jolly, Neethu John, Rahul C. Bhoyar, Nisha Majeed, Vigneshwar Senthivel, Fairoz C. P, et al. 2021. Genomic Survey of Sars-Cov-2 Vaccine Breakthrough Infections in Healthcare Workers from Kerala, India.Journal of Infection (2021) Accepted
Cotsapas C, Saarela J, Farmer JR, Scaria V, Abraham RS. Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? J Clin Invest. 2021 Jun 1:149459. doi: 10.1172/JCI149459


Rophina, M., Pandhare, K., Mangla, M., Shamnath, A., Jolly, B., Sethi, M., & Scaria, V. FaviCoV -a comprehensive manually curated resource for functional genetic variants in SARS-CoV-2.OSF Preprints (2020, November 17). [Preprint]
Jolly B, Rophina M, Shamnath A, Imran M, Bhoyar RC, Divakar M, Rani PR, Ranjan G, Sehgal P, Chandrasekhar P, Afsar S, Vijaya Lakshmi J, Surekha A, Sivasubbu S, Scaria VGenetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomesbioRxiv 2020.12.24.424332; doi: [Preprint]
Rophina M, Pandhare K, Shamnath A, et al. ESC - a comprehensive resource for SARS-CoV-2 immune escape variants. bioRxiv; 2021. DOI: 10.1101/2021.02.18.431922.
Singh, U. B., Rophina, M., Chaudhry, R., Senthivel, V., Bala, K., Bhoyar, R. alGenomic analysis of symptomatic SARS-CoV-2 vaccine breakthrough infections from a tertiary care centre in India. OSF Preprints (2021)

Talks of Interest


The following Projects are open and currently underway. The datasets and results are also listed appropriately.

Genomics of COVID-19 Re-Infections and Breakthrough Infections

The COVID-19 Reinfections observatory aims to compile information on COVID-19 reinfections from across the world as a ready reference. The programme also provides an opportunity to refer potential cases for genomic verification.

The LongCOVID India initiative provides a platform for participatory and collaborative research on LongCOVID in India.

Comparative Genomics and Optimal Diagnostics

The aim of the project would be to compile all primers/probes for screening and diagnosis of SARS CoV-2 infection from across the world. [Project Data and Details]

Genome Analysis and Genetic Epidemiology

The aim of the project is to use public data of SARS CoV-2 genomes for understanding the genetic epidemiology of the epidemic. [Project Data and Details]

Modeling SARS-nCoV2 Epidemic in India

The aim of the project is to develop methods and approaches to accurately model the epidemic in India and also assess the impact of early interventions. [Project Data and Details]

COVID19Connect App

COVID19CONNECT is an application integrating recent information, resources and a platform to connect citizens, patients, clinicians and researchers during the COVID19 epidemic in India. [Mobile App for Android] [Web Application]

The COVID-19 and Rare Diseases initiative aims to quantify the effect of COVID-19 on Rare Disease patients. [Blog Post] [Questionnaire]